St. Luke’s Institute of Pulmonary Medicine partners with international and local respiratory groups for a two-day scientific conference and global PneumoLight landmark illumination.
TAGUIG CITY, PHILIPPINES — November 13, 2026 — As the world observes World Pneumonia Day on November 12, St. Luke’s Medical Center reaffirms its commitment to respiratory care and preventive medicine by hosting a series of high-impact advocacy and scientific initiatives on November 11–12, 2026. Held at the Henry Sy, Sr. Auditorium at St. Luke’s – Global City, the hybrid event brings together global and national medical leaders to address pneumonia—which remains the leading cause of death among communicable diseases in the Philippines and one of the top five causes of mortality worldwide.
Pneumonia is an infection that inflames the air sacs of the lungs, causing them to fill with fluid or pus, making breathing difficult and limiting oxygen intake. While treatable and largely preventable through timely diagnosis, appropriate therapies, and vaccination, pneumonia continues to take a devastating toll, claiming the life of a child under age five every 43 seconds globally.
Comprehensive Scientific & Awareness Program
Organized in partnership with the Philippine College of Chest Physicians (PCCP), the Philippine College of Physicians (PCP), the Philippine Society for Microbiology and Infectious Diseases (PSMID), the Philippine Pediatric Society (PPS), PneumoLight, and the Every Breath Counts Coalition, the event offers both on-site and virtual access for healthcare providers, patients, and health advocates. A session for healthcare workers called “INFACTivity” focuses on the aging lung, immune vulnerability, post-infection recovery, and actionable prevention strategies against respiratory illnesses. The “PneumoLight Conference” is a free hybrid scientific symposium that tackles the shifting epidemiology of respiratory infections, cutting-edge diagnostic pathways, post-pneumonia pulmonary rehabilitation, and multidisciplinary care models.

St. Luke’s also joins over 40 countries and hundreds of iconic global landmarks in illuminating its facade in blue during the Pneumolight illumination movement. This visual demonstration of solidarity aims to bring widespread public visibility to pneumonia prevention, advocating for equitable healthcare access and immunization.
Prioritizing Prevention and Timely Intervention
St. Luke’s Medical Center emphasizes that timely consultation with a pulmonologist or infectious disease specialist is vital whenever individuals experience persistent respiratory symptoms, such as high fever, shortness of breath, chest pain when breathing, or a severe, productive cough.

Through its Institute of Pulmonary Medicine and expert pulmonologists, St. Luke’s offers comprehensive diagnostic evaluations—including high-resolution lung imaging, pulmonary function testing, and targeted antimicrobial management—alongside routine adult and pediatric immunization programs to protect against pneumococcal and seasonal viral infections.
For more information, contact the St. Luke’s Institute of Pulmonary Medicine at (+63 2) 8789-7700 local 2029/ 2034 (St. Luke’s – Global City) or (+63 2) 8723-0101 local 4127/ 5421 (St. Luke’s – Quezon City).



